U
SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
E
Sell
9/16/2024Downgrade
SQZ Biotechnologies Company (SQZB) was downgraded to E+ from D- on 9/16/2024 due to a decline in the volatility index.
SQZ Biotechnologies Company (SQZB) was downgraded to E+ from D- on 9/16/2024 due to a decline in the volatility index.
D
Sell
8/30/2024Upgraded
SQZ Biotechnologies Company (SQZB) was upgraded to D- from E+ on 8/30/2024 due to an increase in the volatility index and total return index.
SQZ Biotechnologies Company (SQZB) was upgraded to D- from E+ on 8/30/2024 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
SQZ Biotechnologies Company (SQZB) was downgraded to E+ from D- on 03/14/2023.
SQZ Biotechnologies Company (SQZB) was downgraded to E+ from D- on 03/14/2023.
D
Sell
3/1/2023Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 3/1/2023 due to a decline in the volatility index and total return index.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 3/1/2023 due to a decline in the volatility index and total return index.
D
Sell
2/9/2023Upgraded
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 02/09/2023.
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
1/27/2023Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 1/27/2023 due to an increase in the volatility index and valuation index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 1/27/2023 due to an increase in the volatility index and valuation index.
D
Sell
11/14/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 11/14/2022 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 0.12 to 0.15, and the quick ratio declined from 3.71 to 3.33.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 11/14/2022 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 0.12 to 0.15, and the quick ratio declined from 3.71 to 3.33.
D
Sell
11/3/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 11/3/2022 due to an increase in the volatility index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 11/3/2022 due to an increase in the volatility index.
D
Sell
10/19/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 10/19/2022 due to a decline in the volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 10/19/2022 due to a decline in the volatility index.
D
Sell
10/3/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 10/3/2022 due to an increase in the volatility index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 10/3/2022 due to an increase in the volatility index.
D
Sell
9/14/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 9/14/2022 due to a decline in the volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 9/14/2022 due to a decline in the volatility index.
D
Sell
8/25/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 8/25/2022 due to an increase in the volatility index and total return index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 8/25/2022 due to an increase in the volatility index and total return index.
D
Sell
8/10/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 8/10/2022 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.1 to 0.12, and the quick ratio declined from 4.17 to 3.71.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 8/10/2022 due to a decline in the volatility index and solvency index. Debt to equity increased from 0.1 to 0.12, and the quick ratio declined from 4.17 to 3.71.
D
Sell
8/5/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 8/5/2022 due to an increase in the volatility index and valuation index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 8/5/2022 due to an increase in the volatility index and valuation index.
D
Sell
7/13/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index.
D
Sell
6/28/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 6/28/2022 due to an increase in the volatility index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 6/28/2022 due to an increase in the volatility index.
D
Sell
6/13/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 6/13/2022 due to a decline in the total return index and volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 6/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 05/16/2022.
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 5/13/2022 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 77.95% from -$11.83M to -$21.05M, earnings per share declined from -$0.4215 to -$0.7475, and total revenue declined 76.77% from $12.35M to $2.87M.
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 5/13/2022 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 77.95% from -$11.83M to -$21.05M, earnings per share declined from -$0.4215 to -$0.7475, and total revenue declined 76.77% from $12.35M to $2.87M.
D
Sell
5/4/2022Upgraded
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 05/04/2022.
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 04/21/2022.
SQZ Biotechnologies Company (SQZB) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index and volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to E+ from D on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
1/11/2022Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 1/11/2022 due to an increase in the volatility index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 1/11/2022 due to an increase in the volatility index.
D
Sell
12/23/2021Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 12/23/2021 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.06 to 0.07, and the quick ratio declined from 4.22 to 4.2.
SQZ Biotechnologies Company (SQZ) was downgraded to D- from D on 12/23/2021 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.06 to 0.07, and the quick ratio declined from 4.22 to 4.2.
D
Sell
11/3/2021Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 11/3/2021 due to an increase in the volatility index.
SQZ Biotechnologies Company (SQZ) was upgraded to D from D- on 11/3/2021 due to an increase in the volatility index.
D
Sell
7/1/2021Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to D- from E on 7/1/2021 due to a large increase in the growth index. Total revenue increased 119.3% from $2.49M to $5.45M, earnings per share increased from -$1.075 to -$0.59, and EBIT increased 12.54% from -$17.62M to -$15.41M.
SQZ Biotechnologies Company (SQZ) was upgraded to D- from E on 7/1/2021 due to a large increase in the growth index. Total revenue increased 119.3% from $2.49M to $5.45M, earnings per share increased from -$1.075 to -$0.59, and EBIT increased 12.54% from -$17.62M to -$15.41M.
E
Sell
4/1/2021Upgraded
SQZ Biotechnologies Company (SQZ) was upgraded to E from E- on 4/1/2021 due to a significant increase in the solvency index and growth index. Earnings per share increased from -$7.0254 to -$1.075, and the quick ratio increased from 2.31 to 3.82.
SQZ Biotechnologies Company (SQZ) was upgraded to E from E- on 4/1/2021 due to a significant increase in the solvency index and growth index. Earnings per share increased from -$7.0254 to -$1.075, and the quick ratio increased from 2.31 to 3.82.
E
Sell
3/3/2021Downgrade
SQZ Biotechnologies Company (SQZ) was downgraded to E- from E on 3/3/2021 due to a significant decline in the volatility index.
SQZ Biotechnologies Company (SQZ) was downgraded to E- from E on 3/3/2021 due to a significant decline in the volatility index.
E
Sell
1/27/2021None
SQZ Biotechnologies Company (SQZB) was downgraded to E from U on 01/27/2021.
SQZ Biotechnologies Company (SQZB) was downgraded to E from U on 01/27/2021.
OTC PK
04/09/2025 3:40PM Eastern
Quotes delayed
